Good time to get shares now during this dip (Nov 3- Dec 12)🧪🧪🧪
Expect it to run up again around the first few weeks of the New Year (Jan 5, 2026)
** Not Financial Advice **
$RXRX
$NVDA is worth $5T (!!!), so I looked at where they’ve been investing...
One caught my eye, $RXRX.
- short interest of 38%
- earnings Nov 5th
- $NVDA investment of $50M at a share price of $6.48
- intersection of biotech + AI + compute infrastructure
I like $RXRX because it's *not* just a drug company, it's a data, compute, AI company in healthcare.
There's cross-sector investor interest too.
aka...biotech investors love it AND AI/tech investors love it, meaning larger investor base and liquidity.
$NVDA is increasing it's reach with a few different strategic partnerships lately (see $NOK...), an expansion of the investment in $RXRX could send it vertical.
Low risk (weekly close under $5), earnings coming, a strategic partnership with a $5T company, and short interest of 38%...
I like this bet, $RXRX now $5.97.
Fed's 25bps cut on 9/17 signals easing amid mixed signals—strong Aug retail (+0.6%) vs job revisions down.
You can use ML to predict volatility from these, spotting overvaluation edges in mega-caps.
Extends bull, but risks bubbles.
What's your model saying?
BANKS DOWN 🔻
TECH CHOP 🌊
REAL ESTATE UP 🟢
UTILITIES DOWN 🔻
CONSUMERS UP 🟢
*FROM NOW TO END OF SEPT/BEGINNING OCT.*
——————————————————————
$SPY UP 🟢
(AFTER A SHORT DIP POSSIBLY)
#StockMarket#SPY#FOMC#FedRateCut